School of Medicine

James B. Lowe III, M.D., chief of the Section of Cosmetic Surgery, admits he’s obsessed with detail. “When I’m in the operating room, every millimeter and every second counts,” he says. “It’s so important to be 100 percent focused in the OR. I go into this zone and nothing can distract me.” With every procedure […]

Clint’s DNA was used to sequence the chimp genome.Comparing the human genome to the chimpanzee genome has allowed scientists to identify changes in the human genetic code that were so advantageous that they rapidly became the norm throughout humanity. The areas of human DNA where these changes occurred are currently the subject of follow-up investigations to identify the potentially vital contributions they now make to human health and development.

Deborah C. Rubin, M.D., has been named director of the Master of Arts and Doctor of Medicine Program (M.A./M.D.) at the School of Medicine.

Taking into account that each of us has unique physical characteristics partly determined by variations in our genes, pharmacogenetics researchers at the School of Medicine are finding ways to personalize cancer treatments.

Commonly refer to them as natural killer cells, they rapidly attack invaders and are continually generated in the bone marrow.

Cardiac researchers have found treatment with anti-inflammatory drugs after heart surgery may lessen or prevent atrial fibrillation.

University researchers used questionnaires, physical examinations and laboratory tests to assess symptoms and disability levels.

The National Cancer Institute has awarded the center a five-year, $1.25 million grant to support its Program for the Elimination of Cancer Disparities.

However, Medicaid, Medicare and many private insurers specify CT (computed tomography) for diagnosing and monitoring this cancer.

Applications are being accepted for the University’s American Cancer Society Institutional Research Grant.